ACADIA Pharmaceuticals Inc ACAD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:58 PM EDT
16.90quote price arrow down-0.21 (-1.23%)
Volume
119,879
Close
17.11quote price arrow up+0.28 (+1.66%)
Volume
1,187,884
52 week range
15.16 - 28.05
Loading...
  • Open17.01
  • Day High17.21
  • Day Low16.26
  • Prev Close16.83
  • 52 Week High28.05
  • 52 Week High Date04/07/22
  • 52 Week Low15.16
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap2.762B
  • Shares Out161.43M
  • 10 Day Average Volume1.88M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change-26.69

KEY STATS

  • Open17.01
  • Day High17.21
  • Day Low16.26
  • Prev Close16.83
  • 52 Week High28.05
  • 52 Week High Date04/07/22
  • 52 Week Low15.16
  • 52 Week Low Date05/12/22
  • Market Cap2.762B
  • Shares Out161.43M
  • 10 Day Average Volume1.88M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change-26.69

RATIOS/PROFITABILITY

  • EPS (TTM)-1.33
  • P/E (TTM)-12.87
  • Fwd P/E (NTM)-13.06
  • EBITDA (TTM)-213.687M
  • ROE (TTM)-41.79%
  • Revenue (TTM)493.06M
  • Gross Margin (TTM)96.55%
  • Net Margin (TTM)-43.50%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ACADIA Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Acadia Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops and commercializes novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The Company’s pipeline product candidates in CNS areas includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP)....
Stephen Biggar M.D., Ph.D.
Independent Chairman of the Board
Stephen Davis CPA
Chief Executive Officer, Principal Financial Officer, Director
Srdjan Stankovic M.D.
President
Brendan Teehan
Chief Operating Officer, Executive Vice President and Head of Commercial
Mark Schneyer
Chief Financial Officer, Executive Vice President
Austin Kim
Executive Vice President, General Counsel, and Secretary
Address
3611 Valley Centre Dr Ste 300
San Diego, CA
92130-3331
United States

Top Peers

SYMBOLLASTCHG%CHG
ABCL
Abcellera Biologics Inc
7.90-0.40-4.82%
PTCT
PTC Therapeutics Inc
32.33-0.17-0.52%
NTRA
Natera Inc
39.96+0.99+2.54%
FOLD
Amicus Therapeutics Inc
7.76+0.34+4.58%
GH
Guardant Health Inc
36.77+2.02+5.81%